Trends in Serum Lipid Profile in HIV, Tuberculosis and Tuberculosis/HIV Co-Infected Patients at Three-Day Care Centres in Fako Division, Southwest Region of Cameroon
DOI:
https://doi.org/10.30442/ahr.1004-09-260Abstract
Background: Despite the reasonable goals and achievements with Antiretroviral (ARV) Therapy and Anti-Tuberculosis Drugs (ATD), several metabolic disturbances, such as abnormal serum lipid profile, have been observed during treatment with ARVs and ATD.
Objectives: To evaluate serum lipid profile in HIV and TB patients (before and after initiation of treatment) and their association with some possible risk factors.
Methods: One hundred and twenty-five patients were consecutively recruited at initiation to treatment and followed up for 12 weeks. Serum Total-Cholesterol (TC), High-Density-Lipoprotein-Cholesterol (HDLc), Low-Density Lipoprotein-Cholesterol (LDLc) and Triglycerides (TG) were measured spectrophotometrically to determine the serum lipid profile of participants.
Results: A significant association was recorded comparing the cumulative incidence of abnormal serum lipid profile (HDLc and LDLc) of the study participants before the initiation of treatment and after initiation of therapy, with a 2.26 and 3.57 times likelihood of those on treatment to developing abnormal HDL and LDLc respectively (χ2 =7.4, p = 0.007; O.R; 2.26, 95% C.I; 1.25-4.10; χ2 =14.79, p = 0.00012; O.R; 3.57, 95% C.I; 1.82-6.98, respectively). There was a significant association between the level of TC and the type of drug regimen, with those on ATD/HAART having a higher frequency (8/17(47.1%)) of abnormal TC compared to their counterpart. There is a significant association between the level of TG and body mass index BMI (χ2 = 13.95, p = 0.003).
Conclusion: This study shows TB and HIV/AIDS alter lipid levels, and their respective treatments can exacerbate these effects, with TC levels being affected significantly by combination ATD/HAART therapy. Therefore, understanding these changes is crucial to patient management.
References
Sarkar S, Brown TT. Lipid Disorders in People with HIV. [Updated 2023 21 January]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK567198/(Accessed 14th February 2024).
Natesan V, Kim SJ. Lipid Metabolism, Disorders and Therapeutic Drugs - Review. Biomol Ther (Seoul) 2021;29:596-604. https://doi.org/10.4062/biomolther.2021.122.
Zhang Y, Xiao J, Zhang W, Han N, Yang D, Liu W, et al. Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy. J Infect Dev Ctries 2022;16:528–536. https://doi.org/10.3855/jidc.12519.
Ahmed N, Amjad I, Abbas MZ, Naseer A, Raza M, Imtiaz A, et al. Effects of Anti-Tuberculosis Drugs on Lipid Profile in Pulmonary Tuberculosis Patients. J Dow Univ Health Sci 2022;16:78-82. https://doi.org/10.36570/jduhs.2022.2.1235.
Bansal CB, Arun P, Nachiappan S, Ajay C, Amit M, Sukriti B, et al. Abnormal Lipids and Acquired Immune Deficiency Syndrome: Association of Serum Lipids with HIV Status. Prensa Med Argent 2020;106:4.300. https://doi.org/10.47275/0032-745X-300
Hofmaenner DA, Arina P, Kleyman A, Black LP, Salomao R, Tanaka S, et al. Association Between Hypocholesterolemia and Mortality in Critically Ill Patients with Sepsis: A Systematic Review and Meta-Analysis. Critical Care Explorations 2023;5:e0860. https://doi.org/10.1097/CCE.0000000000000860.
Musharaf MS, Riaz S, Shoaib Nabi M, Usman U, Javaid A. Evaluation of Lipid Profile in Newly Diagnosed Tuberculous Patients. Pak J Chest Med 2021;26:181-186. https://www.pjcm.net/index.php/pjcm/article/view/67.
Enoh JE, Ngu FA. Evaluation of risk factors/prevalence of insulin resistance, diabetes mellitus, hypertension and central obesity in people living with HIV/AIDS at the Bamenda Regional Hospital. Recent Adv Natural Sci 2024;2:101. https://doi.org/10.61298/rans.2024.2.2.101
Temesgen F, Worku A, Henok D, Zemenu TAG. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia. PLoS ONE 2021;16: e0250328. https://doi.org/10.1371/journal.pone.0250328
National Institute on Alcohol Abuse and Alcoholism. Alcohol's Effects on Health; Research-based information on drinking and its impact. https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking (Accessed November 2023)
Manjula D. Nugawela, Tessa Langley, Lisa Szatkowski, Sarah Lewis. Measuring Alcohol Consumption in Population Surveys: A Review of International Guidelines and Comparison with Surveys in England. Alcohol and Alcoholism 2016;51:84–92, https://doi.org/10.1093/alcalc/agv073
Development of the roadmap and guidelines for the prevention and management of high blood pressure in Africa: Proceedings of the PASCAR Hypertension Task Force meeting: Nairobi, Kenya, 27 October 2014. Abstract Europe PMC. Available from: https://europepmc.org/article/MED/25940121?singleResult=true (Accessed November 2023).
Zhao P, Liu S, Zhong Z. Age and sex-related difference of lipid profile in patients with ischemic stroke in China. Medicine 2018;97. https://doi.org/10.1097/MD.0000000000010930
Shabana, Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis 2020;19:73. https://doi.org/10.1186/s12944-020-01248-0.
Herbert C, Luies L, Loots DT, Williams, AA. The metabolic consequences of HIV/TB co-infection. BMC Infect Dis 2023;8;23:536. https://doi.org/10.1186/s12879-023-08505-4.
Wilson PWF, Jacobson TA, Martin SS, Jackson EJ, Le NA, Davidson MH, et al. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the National Lipid Association writing group. J Clin Lipidol 2021;15:629–648. https://doi.org/10.1016/j.jacl.2021.09.046
Marin-Palma D, Castro GA, Cardona-Arias JA, Silvio UI, Hernandez JC. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated with Increased Inflammatory Markers and Disease Progression. Frontiers Immunol 2018;9:363364. https://doi.org/10.3389/fimmu.2018.01350
Chihota BV, Mandiriri A, Shamu T, Muula G, Nyamutowa H, Taderera C, et al. Metabolic syndrome among treatment-naïve people living with and without HIV in Zambia and Zimbabwe: A cross-sectional analysis. J Int AIDS Soc 2022;25:e26047. https://doi.org/10.1002/jia2.26047
Rakovac TA, Crowley VEF, Crook MA. Undetectable high-density lipoprotein cholesterol in acute malaria. J Clin Lipidol 2018;12:822-825. https://doi.org/10.1016/j.jacl.2018.02.019
Megabiaw F, Eshetu T, Kassahun Z, Aemero M. Liver Enzymes and Lipid Profile of Malaria Patients Before and After Antimalarial Drug Treatment at Dembia Primary Hospital and Teda Health Center, Northwest, Ethiopia. Res Rep Trop Med 2022;28:11-23. https://doi.org/10.2147/RRTM.S351268.
Feingold KR. Obesity and Dyslipidemia. [Updated 2023 19 June]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305895/(Accessed 14th February 2024)
Ali AA, Fasen M, Kintin Ng, Patrisha S. Lipaemic blood: Alcohol-induced acute hypertriglyceridaemia. BMJ Case Reports 2021;14:e243167. https://doi.org/10.1136/bcr-2021-243167.
Rosoff DB, Charlet K, Jung J, Lee J, Muench C, Luo A, et al. Association of High-Intensity Binge Drinking with Lipid and Liver Function Enzyme Levels. JAMA Network Open 2019;2:e195844. https://doi.org/10.1001/jamanetworkopen.2019.5844.
Yang L, Yang C, Thomes PG, Kharbanda KK, Casey CA, McNiven MA, et al. Lipophagy and Alcohol-Induced Fatty Liver. Frontiers Pharmacol 2019;10:495. https://doi.org/10.3389/fphar.2019.00495
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Molecular Metab 2018;15:45–55. https://doi.org/10.1016/j.molmet.2018.05.008
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 2017;135:e146–e603. https://doi.org/10.1161/CIR.0000000000000485
Vaughan AS, Schieb L, Casper M. Historic and recent trends in county-level coronary heart disease death rates by race, gender, and age group, United States, 1979-2017. PLoS ONE 2020;15:e0235839. https://doi.org/10.1371/journal.pone.0235839
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria, OOUTH, Sagamu, Nigeria)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.
